Amrize (NYSE:AMRZ) Rating Lowered to Sell at Wall Street Zen

Amrize (NYSE:AMRZ) was downgraded by stock analysts at Wall Street Zen from a “hold” rating to a “sell” rating in a research note issued to investors on Saturday.

Several other research analysts also recently commented on AMRZ. Oppenheimer reiterated an “outperform” rating and issued a $70.00 price objective (up previously from $64.00) on shares of Amrize in a report on Thursday. Weiss Ratings raised Amrize from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Wednesday, February 11th. Truist Financial boosted their price objective on Amrize from $60.00 to $75.00 and gave the company a “buy” rating in a research report on Friday. Vertical Research assumed coverage on shares of Amrize in a report on Tuesday, November 25th. They issued a “hold” rating and a $54.00 target price on the stock. Finally, UBS Group lifted their target price on shares of Amrize from $53.00 to $57.00 and gave the stock a “neutral” rating in a research note on Thursday, January 8th. One research analyst has rated the stock with a Strong Buy rating, nine have given a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $63.43.

Amrize Trading Up 1.8%

Shares of AMRZ opened at $65.06 on Friday. The firm has a market cap of $35.98 billion and a price-to-earnings ratio of 35.36. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.97 and a current ratio of 1.64. Amrize has a fifty-two week low of $44.12 and a fifty-two week high of $65.26. The firm has a 50 day moving average price of $56.08 and a 200-day moving average price of $52.48.

Amrize (NYSE:AMRZ) last released its earnings results on Tuesday, February 17th. The company reported $0.62 EPS for the quarter, beating the consensus estimate of $0.59 by $0.03. The business had revenue of $2.84 billion for the quarter, compared to the consensus estimate of $2.95 billion. The firm’s quarterly revenue was down .4% on a year-over-year basis.

Institutional Trading of Amrize

Large investors have recently added to or reduced their stakes in the stock. Rothschild Investment LLC grew its position in shares of Amrize by 4.3% in the 4th quarter. Rothschild Investment LLC now owns 6,835 shares of the company’s stock worth $370,000 after buying an additional 280 shares during the period. Baldwin Investment Management LLC boosted its stake in Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock worth $486,000 after acquiring an additional 375 shares in the last quarter. Itau Unibanco Holding S.A. grew its holdings in Amrize by 150.0% in the fourth quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after purchasing an additional 450 shares during the period. Caitong International Asset Management Co. Ltd lifted its holdings in shares of Amrize by 141.3% during the fourth quarter. Caitong International Asset Management Co. Ltd now owns 847 shares of the company’s stock valued at $46,000 after purchasing an additional 496 shares during the last quarter. Finally, MCF Advisors LLC purchased a new position in shares of Amrize during the fourth quarter valued at approximately $27,000.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.